Search

Your search keyword '"Bruno Ferraz-de-Souza"' showing total 76 results

Search Constraints

Start Over You searched for: Author "Bruno Ferraz-de-Souza" Remove constraint Author: "Bruno Ferraz-de-Souza"
76 results on '"Bruno Ferraz-de-Souza"'

Search Results

2. Prevention and treatment of oral adverse effects of antiresorptive medications for osteoporosis – A position paper of the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Stomatology and Oral Pathology (Sobep), and Brazilian Association for Bone Evaluation and Osteometabolism (Abrasso)

Catalog

Books, media, physical & digital resources

3. Acute and long-term kidney function after parathyroidectomy for primary hyperparathyroidism.

4. Transcriptomic Response to 1,25-Dihydroxyvitamin D in Human Fibroblasts with or without a Functional Vitamin D Receptor (VDR): Novel Target Genes and Insights into VDR Basal Transcriptional Activity

5. 25-Hydroxyvitamin D and TSH as Risk Factors or Prognostic Markers in Thyroid Carcinoma.

6. Genetics of osteoporosis: searching for candidate genes for bone fragility

7. Diagnosis and treatment of hypoparathyroidism: a position statement from the Brazilian Society of Endocrinology and Metabolism

10. Guia Prático em Osteometabolismo

11. Prevention and treatment of oral adverse effects of antiresorptive medications for osteoporosis – A position paper of the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Stomatology and Oral Pathology (Sobep), and Brazilian Association for Bone Evaluation and Osteometabolism (Abrasso)

12. Genetic Analysis of Pediatric Primary Adrenal Insufficiency of Unknown Etiology: 25 Years’ Experience in the UK

13. Comprehensive Genetic Analysis of 128 Candidate Genes in a Cohort With Idiopathic, Severe, or Familial Osteoporosis

14. MON-333 Cutaneous Skeletal Hypophosphatemic Syndrome (Cshs) Caused by Somatic HRAS p.G13R Mutation: Long Follow-Up of Two Brazilian Women

15. Acute and long-term kidney function after parathyroidectomy for primary hyperparathyroidism

16. Real-world impact of glucocorticoid replacement therapy on bone mineral density: retrospective experience of a large single-center CAH cohort spanning 24 years

17. OR13-5 The Molecular Landscape of Osteogenesis Imperfecta in a Brazilian Tertiary Service Cohort

18. SUN-359 Preserved Bone Mineral Density In Adults With Classical Forms Of Congenital Adrenal Hyperplasia Submitted To Long-term Low Glucocorticoid Doses

19. Nonspecific binding of a frequently used vitamin D receptor (VDR) antibody: important implications for vitamin D research in human health

20. The elusive clinical significance of osteocalcin actions in energy metabolism in humans

21. Diagnosis and treatment of hypoparathyroidism: a position statement from the Brazilian Society of Endocrinology and Metabolism

22. Normal bone mass and normocalcemia in adulthood despite homozygous vitamin D receptor mutations

23. Transcriptomic Response to 1,25-Dihydroxyvitamin D in Human Fibroblasts with or without a Functional Vitamin D Receptor (VDR): Novel Target Genes and Insights into VDR Basal Transcriptional Activity

24. Diagnóstico e tratamento da doença de Paget dos ossos: uma minirrevisão

25. Wide spectrum of NR5A1-related phenotypes in 46,XY and 46,XX individuals

26. Effects of Type 1 Insulin-Like Growth Factor Receptor Silencing in a Human Adrenocortical Cell Line

27. Symptomatic intracranial hypertension and prolonged hypocalcemia following treatment of Paget’s disease of the skull with zoledronic acid

28. Mutations in the PCNA-binding domain of CDKN1C cause IMAGE Syndrome

29. Sterol O-Acyltransferase 1 (SOAT1, ACAT) Is a Novel Target of Steroidogenic Factor-1 (SF-1, NR5A1, Ad4BP) in the Human Adrenal

30. ChIP‐on‐chip analysis reveals angiopoietin 2 (Ang2, ANGPT2) as a novel target of steroidogenic factor‐1 (SF‐1, NR5A1) in the human adrenal gland

31. CBP/p300-Interacting Transactivator, with Glu/Asp-Rich C-Terminal Domain, 2, and Pre-B-Cell Leukemia Transcription Factor 1 in Human Adrenal Development and Disease

32. Heterozygous Missense Mutations in Steroidogenic Factor 1 (SF1/Ad4BP, NR5A1) Are Associated with 46,XY Disorders of Sex Development with Normal Adrenal Function

33. Five novel mutations in steroidogenic factor 1 (SF1,NR5A1) in 46,XY patients with severe underandrogenization but without adrenal insufficiency

34. POD-1/TCF21 Reduces SHP Expression, Affecting LRH-1 Regulation and Cell Cycle Balance in Adrenocortical and Hepatocarcinoma Tumor Cells

35. Feocromocitoma

36. Homozygous inactivating mutation in NANOS3 in two sisters with primary ovarian insufficiency

37. POD-1 binding to the E-box sequence inhibits SF-1 and StAR expression in human adrenocortical tumor cells

38. Potential effects of alendronate on fibroblast growth factor 23 levels and effective control of hypercalciuria in an adult with Jansen's metaphyseal chondrodysplasia

40. Role of DAX-1 (NR0B1) and steroidogenic factor-1 (NR5A1) in human adrenal function

41. Role of DAX-1 (NR0B1) and Steroidogenic Factor-1 (NR5A1) in Human Adrenal Function

42. Steroidogenic factor-1 (SF-1, NR5A1) and human disease

43. Adrenals

44. Disorders of adrenal development

45. Disorders of Adrenal Development

46. Adrenals

47. Genetic disorders involving adrenal development

49. Diagnóstico molecular na prática clínica: visão do endocrinologista

50. Steroidogenic factor-1 (SF-1) and its relevance to pediatric endocrinology